← FDA DRUG APPROVALS

FDA ANDA · ANDA073092

BACLOFEN

Sponsor: WATSON LABS

APPLICATION
ANDA073092
TYPE
ANDA
ORIGINAL APPROVAL
1994-01-28
LATEST ACTION
2020-05-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BACLOFENDiscontinued
BACLOFEN 10MG · TABLET · ORAL

Approval history

2020-05-06Labeling · Supplement 16 · standardAP
2001-04-12Manufacturing (CMC) · Supplement 15AP
2000-03-21Manufacturing (CMC) · Supplement 13AP
1998-01-20Manufacturing (CMC) · Supplement 11AP
1997-07-08Manufacturing (CMC) · Supplement 9AP
1997-03-26Manufacturing (CMC) · Supplement 3AP
1997-02-28Manufacturing (CMC) · Supplement 7AP
1997-01-07Manufacturing (CMC) · Supplement 8AP
1996-12-31Manufacturing (CMC) · Supplement 5AP
1996-12-31Manufacturing (CMC) · Supplement 4AP
1996-01-17Manufacturing (CMC) · Supplement 2AP
1994-10-13Manufacturing (CMC) · Supplement 1AP
1994-01-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →